Search

everythinglearnresearchcommunity

for

Search:↓

Balding hair follicles have reduced growth factors and increased inhibitory factors, suggesting new treatment paths for hair loss.

Changing hair follicle identity could potentially reverse balding.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Alopecia areata affects hair follicle structure, even in non-balding areas.

miR-122 causes hair loss by killing hair cells.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

The research found that certain factors in hair follicle cells control hair growth and development, and these could be used to create new treatments for hair loss.

Oxidative stress contributes to hair graying and loss as we age.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

Melanoma risk tools need improvement, a gene mutation causes a hair disorder that might be treated by managing cell stress, a potential therapy for a skin-ear disorder involves blocking cell channels, skin wrinkling may indicate lung aging regardless of smoking, and oxidative stress might contribute to common baldness.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Increasing alkaline phosphatase in human skin cells helps to grow more hair.

Hair loss in men might be linked to changes in cell energy factories.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

Caffeine and DMG increase calcium influx in hair follicle cells without being toxic.

Targeting specific genes in certain pathways may help treat male pattern baldness.

Reducing PEDF may help treat hair loss.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Early attempts at using cloned cells for hair transplants failed, but 3D cell growth showed some promise.

Minoxidil promotes hair growth but exact mechanism is unknown.